Lazard Asset Management
CELL

Lazard Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Lazard Asset Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-298,188
Closed -$146K – 2531
2023
Q2 		$146K Sell
298,188
-8,157
-3% -$6.67K ﹤0.01% 1439
2023
Q1 		$354K Buy
306,345
+10,503
+4% +$19.2K ﹤0.01% 1174
2022
Q4 		$792K Sell
295,842
-253,254
-46% -$668K ﹤0.01% 1041
2022
Q3 		$1.57M Buy
549,096
+20,381
+4% +$86.7K ﹤0.01% 928
2022
Q2 		$2.63M Buy
528,715
+187,289
+55% +$981K ﹤0.01% 854
2022
Q1 		$2.43M Buy
341,426
+81,236
+31% +$672K ﹤0.01% 865
2021
Q4 		$4.73M Buy
260,190
+162,101
+165% +$3.5M 0.01% 780
2021
Q3 		$1.92M Buy
98,089
+25,428
+35% +$967K ﹤0.01% 920
2021
Q2 		$3.25M Buy
72,661
+71,760
+7,964% +$3.33M ﹤0.01% 785
2021
Q1 		$45K Buy
+901
New +$61.4K ﹤0.01% 1490

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lazard Asset Management's CELL Position: Q3 2023 in Review

Lazard Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 298,188 shares — an estimated $146K sold.

Lazard Asset Management first reported a position in CELL in Q1 2021 and held it in 10 quarters. The position peaked at $4.73M in Q4 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Lazard Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lazard Asset Management sold 298,188 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $146K.
  • Lazard Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Lazard Asset Management's PhenomeX Inc. Common Stock position peaked at $4.73M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Lazard Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.